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Second-generation probes for biosynthetic
intermediate capture: towards a comprehensive
profiling of polyketide assembly†
Ina Wilkening,‡a Silvia Gazzola,‡§ab Elena Riva,a James S. Parascandolo,a
Lijiang Songa and Manuela Tosin*a
Malonyl carba(dethia) N-decanoyl cysteamine methyl esters and
novel acetoxymethyl esters were utilised as second-generation
probes for polyketide intermediate capture. The use of these tools
in vivo led to the characterisation of an almost complete set of
biosynthetic intermediates from a modular assembly line, providing
a first kinetic overview of intermediate processing leading to complex
natural product formation.
Polyketide natural products are ubiquitous in their distribution
and remarkably varied in structure and biological function.1
Amongst them we encounter established potent antibiotics
(e.g. fidaxomicin),2,3 anticancer agents (e.g. doxorubicin)4 and
cholesterol-lowering agents (e.g. statins),5 as well as promising
leads for the development of modulators of stem cell behaviour
(e.g. salinomycin).6 Polyketide biosynthesis proceeds via the
decarboxylative Claisen condensation of acyl carrier protein
(ACP) bound-malonyl units with ketosynthase (KS)-bound acyl
intermediates (Fig. 1, A): the resulting polyketide chain is
subjected to variable ketoreduction, dehydration and enoyl
reduction throughout chain extension, before being released
from the polyketide synthase (PKS) enzyme (typically via thio-
ester hydrolysis) and further modified by post-PKS enzymes
(e.g. methyltransferases, glycosyltransferases, cytochrome P450s,
etc.).7–9 The detailed elucidation of polyketide biosynthesis is of
the utmost priority in view of enzyme engineering for novel
synthetic biology aiming at polyketide production:10–12 indeed
the knowledge of intermediate processing is crucial to improve
the functioning of current pathways and to design de novo
pathways leading to both high-value13 and commodity chemicals.14
Advances inmolecular biology, synthetic chemistry and analytical
techniques have allowed the probing of PKS pathways via recon-
stitution of enzyme activity in vitro15 and in vivo genetic manip-
ulation leading to the accumulation of intermediate or shunt
products,16 for which the detection and the characterisation of
small molecule intermediates/products by advanced MS and
NMR have proved crucial.17–19 Nonetheless, many challenges
concerning the ability to monitor polyketide biocatalysis step-
wise, especially in vivo and in relation to whole assembly kinetics,
remain. One of the major hurdles is constituted by the covalent
attachment of biosynthetic intermediates to the biosynthetic PKS
enzymes throughout PKS assembly. In recent years we have
developed a general strategy for probing polyketide biocatalysis
based on the use of chemical probes (Fig. 1): nonhydrolysable
small-molecule mimics of malonate units recruited in polyketide
Fig. 1 Polyketide intermediate capture by chemical probes 5–8: these
interfere with the normal biosynthetic pathway (A) and undergo compe-
titive decarboxylative Claisen condensation with KS-bound intermediates
to off-load them (B). Advanced captured species constitute also novel
unnatural product derivatives (e.g. 9–12).23 las A = lasalocid A polyketide
synthase; KS = ketosynthase; AT = acyltransferase; ACP = acyl carrier protein;
TE = thioesterase.
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formation compete in the natural decarboxylative Claisen con-
densation (A) to capture prematurely truncated biosynthetic
intermediates (B) which would otherwise remain covalently
bound to PKSs.20–25 This approach has proved successful for
the isolation and characterisation of intermediate species from
both modular20–23 and iterative polyketide synthases24,25 in vitro
and in vivo, allowing the gathering of information on the timing
and themechanism of single catalytic events otherwise inaccessible.
Lately we also demonstrated that this methodology is amenable
for the generation of unnatural polyketide derivatives: for
instance, novel polyether species were obtained in low titre
from feeding experiments of mutant strains of Streptomyces
lasaliensis (harbouring the modular PKS responsible the
production of the polyether antibiotic lasalocid A) with func-
tionalised chemical probes (Fig. 1).23 Moreover the use of the
probes with strains harbouring 6-methylsalicylic acid synthase
(a type I iterative PKS) has led to the generation of unnatural
functionalised pentaketides.25 During our studies towards the
improvement of polyketide capture, it occurred to us that probe
bioavailability could be a crucial limiting factor: indeed the
hydrolysis of the methyl ester probes 1–4 by cellular esterases
has been estimated to be in the range of 5–70%, depending on
the nature of the probe (Fig. 1) and of the polyketide producing-
microorganism. Therefore we decided to investigate whether,
by changing the probe ester protection, a higher concentration
of the ‘active’ carboxylate species 5–8 could be systematically
achieved in vivo, ultimately leading to improved intermediate
capture and kinetic insights on polyketide assembly. In explor-
ing possible protecting groups that would be easily hydrolysed
in vivo, we considered the use of acetoxymethyl ester (AM)
moieties. AM esters, notably introduced by Tsien for loading
fluorescent indicators into cells,26 are widely employed in
prodrugs27 and chemical probes28 in eukaryotic cells to mask
hydrophilic/charged bioactive functionalities, allowing effective
compound cellular uptake through membrane permeation.
The AM functionality and structural variants of it have been
used to protect, directly and indirectly, a wide variety of groups,
including alcohols,29 amines,30 phosphates31 and carboxylic
acids.32,33 To the best of our knowledge, it has not been yet
utilised for the protection of b-keto carboxylic acid derivatives,
and reports on the use of AM protected substrates in prokaryote
cells are scarce. We first targeted the preparation of esters
15a–b according to Scheme 1. Briefly, the carbonyl groups of
the methyl esters 1a–b were protected by conversion either
to the ketals 13a–b by reaction with 1-phenyl-1,2-ethanediol
and chlorotrimethylsilane in reflux conditions (route 1),34 or
to thioketals 17a by reaction with 1,2-ethanediol and boron
trifluoride diethyl etherate (route 2). 13a–b and 16a were then
hydrolysed to the corresponding carboxylates by treatment with
potassium trimethyl silanolate,35 and converted to the acetoxy-
methyl esters 14a–b and 17a by reaction with bromomethyl
acetate in dry THF. Finally, the desired compounds 15a–b were
obtained by hydrogenation of 14a–b over Pd(OAc)2 and Pd(OTf)2
catalysts in dry ethyl acetate (route 1),36 or by treatment of 17a with
[bis-(trifluoroacetoxy)iodo]benzene (route 2). AM esters are known
to spontaneously hydrolyse over time, even in neutral conditions.
Therefore 15a–b were promptly purified by HPLC and stored for
a limited amount of time at low temperature and in a lyophilised
form prior to their use. S. lasaliensis ACP12 (S970A), for which
late-stage intermediates of lasalocid A have been extensively
characterised,22,23 was chosen as our in vivo model system to
evaluate the efficiency of the ‘second-generation’ AM ester probes
15a–b in comparison to the first-generation methyl esters 1a–b.
LC-HRMS analyses of the ethyl acetate extracts of S. lasaliensis
ACP12 (S970A) grown with gradual addition of probes 15a–b
(0.4–0.8 mM) over 5 days revealed their quantitative hydrolysis to
5a–b and the presence of significant higher amounts of the
unnatural polyethers 9a–b (Fig. 2). Several careful repetitions of
these experiments and LC-MS analyses optimisation have
Scheme 1 Synthesis of novel acetoxymethyl ester probes 15a–b and 20.
Reagents and conditions: (a) PhCH(OH)CH2OH, TMSCl, CH2Cl2, reflux, 90%;
(b) KOTMS, THF, 3 h, 86–100%; (c) BrCH2OAc, THF, 40–98%; (d) Pd(OAc)2,
Pd(OTf)2, H2(g), EtOAc, 48 h, 40% (after HPLC purification); (e) HS(CH2)2SH,
BF3Et2O, CH2Cl2, reflux, 61–90%; (f) (CF3CO2)2IC6H5, CH3CN, H2O, 78–82%
(after HPLC purification).
Fig. 2 Comparative micro LC-HRMS analysis (Bruker MaXis UHR-ESI-TOF)
of the organic extracts of S. lasaliensis ACP12 (S970A) grown in the presence
of 1a and 15a. (A) [M + Na]+ extracted ion traces for probes 1a (top) and 15a
(bottom), and their hydrolysis/decarboxylation product 21a after 5 days of
fermentation; (B) detection of species 9a (sum of [M + Na]+ and [M + NH4]
+
adducts): the amount captured by 15a (continuous line) is approximately one
order of magnitude higher than that obtained by 1a (dashed line). The
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allowed us to estimate that up to ten times more of 9a was
generated using the AM probes 15a in comparison to its methyl
ester counterparts 1a. Whereas the AM probes 15a–b led to
increased amounts of 9a–b, no additional polyketide species
could be detected in the organic extracts. In a variety of previous
in vivo experiments, we noticed that N-decanoyl probes methyl
ester probes such as 3 (Fig. 1) seemed capable of off-loading
relatively short intermediates from both modular and iterative
PKSs,23–25 possibly due to increased hydrophobicity of the probe
or a better mimicking of the phosphopantetheine cofactor.
Therefore we decided to pursue the preparation of N-decanoyl
AM ester probe 20 following route 2 of Scheme 1. When both 3
and 20 were utilised in feeding experiments, further enhance-
ment in the titre of captured intermediates was clearly observed
in comparison to those deriving from short chain probes 1 and
15: this seemed to mirror the higher concentrations of active
probe 7 generated in vivo, especially from the AM precursor 20
(B95%, Fig. S26, ESI†). More crucially, biosynthetic intermediates
of different chain length and degree of processing were off-loaded
from all the lasA modules with the exception of module 10 (Fig. 3
and ESI†). As well as expected species which were previously
undetected, we also observed a number of unexpected overly
processed dodecaketides (Fig. 3 and ESI†). These were unequivocally
identified by the m/z 377 fragment (typical of lasalocid deriva-
tives) obtained by high resolution MS2 (Fig. S47 and S48).
Similar intermediates were obtained and confirmed from the
use of the azido probe 8 and further intermediate functionalisation
by Staudinger-phosphite reaction as previously reported23 (ESI†).
The mechanism and the timing of transformations leading to
lasalocid A assembly have been previously investigated by us and
by others.22,37 Also, spontaneous offloading of PKS biosynthetic
intermediates has been occasionally reported from the fermenta-
tion of wild-type and engineered bacterial strains.38,39 Herein, we
have been able to obtain for the first time a comprehensive and
stepwise picture of PKS modular assembly as a result of
an improved chemical chain termination strategy. Diketides,
pentaketides and dodecaketides were the most frequently and
abundantly observed species for S. lasaliensis ACP12 (S970A)
(highlighted in Fig. 3, see also ESI†), whereas the capture
of intermediates from modules 9 to 11 proved particularly
challenging. In this context the use of the AM ester probe 20
proved more advantageous than the corresponding methyl
ester 3 in that it lead to increased amounts of captured species
aiding their identification and characterisation. The accumula-
tion of intermediates in higher amounts from specific modules
of the lasA PKS possibly arises from: (1) slower enzymatic steps
taking place within particular modules and within the whole
PKS, including different extent of KS site priming and inter-
domain intermediate translocation, and/or (2) different active
site accessibility and capability of diffusion for the probe and
the off-loaded intermediates. Despite the abundance of kinetic
data available for modular enzymatic constructs in vitro,40–42
the rate-determining steps of whole complex PKS biosynthetic
pathways remain unclear. In our experiments, we observed
condensation products of the chemical probes with KS-bound
intermediates in most cases, however the abundance of these
species varies across modules, suggesting that either the
different Claisen condensation steps proceed at different rates,
or that KS-priming varies within a whole PKS as a result of
intermediate chain transfers across modules. In addition, the
intermediates captured from different modules present different
degree and extent of processing, which likely result from different
rates of the individual KR-, DH- and ER-catalysed steps and/or
from differential substrate accessibility to their active sites. On
the basis of the data herein gathered, which show the detection
of diketide, pentaketide and dodecaketide species in higher
frequency and abundance, we propose that intermediate
processing between modules 1 and 2, 4 and 5, and 11 and 12
Fig. 3 Overview of intermediates captured from S. lasaliensis ACP12 (S970A) via ester probes 3 and 20. Coloured boxes have been used to diﬀerentiate the
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(including intermediate aromatisation) is slower compared to that
occurring at other stages of PKS assembly: this is related either to
the rapidity of intra- or inter-modular processing, or likely to a
combination of both. For modular PKSs a ‘turnstile’42 or ‘retarda-
tion’43 mechanism control has been proposed, for which any
ketosynthase of a modular PKS is not primed until completion of
intermediate processing and transfer of the module product to the
downstream KS: this would account for the unidirectionality of
intermediate processing in co-linear pathways and may be con-
trolled by the release of carbon dioxide following decarboxylative
Claisen condensation.42 Also, a number of structural models for
selected PKS modules have recently become available on the basis
of cryo-electron microscopy44,45 and small-angle-X-ray-scattering
analyses:46,47 these preliminary results show a single reaction
chamber into which most of the domain active sites face. The
unexpected presence of overly processed dodecaketides, formally
deriving from ketoredution and dehydration reactions of an
expected dodecaketide yet to be aromatised (see Fig. 3 and ESI†),
suggests that dodecaketide diffusion into the adjacent module 11
bearing active KR and the DH domains may have taken place.
Whereas substrate diffusion across adjacent domains has been
documented in vitro,41 free substrate diffusion to adjacent modules
in vivo has yet to be reported and is currently under investigation.
In conclusion, we developed novel chemical probes of
enhanced bioavailability that allowed the gathering of preliminary
kinetic insights into complex natural product assembly in vivo:
these hold intriguing implications for the development of novel
synthetic biology aiming at novel polyketide production.10–12,48–50
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